Tag Archives: Prostate

Popular drugs used for treating enlarged prostates associated with high-grade prostate cancer

If a man has an enlarged prostate, there’s a good chance he’ll be treated with a type of drug called a 5-alpha reductase inhibitor (5-ARI). These drugs shrink the gland to improve urinary flow, and the approved forms used for treating enlarged prostates come in two varieties: Proscar (finasteride) and Avodart (dutasteride). However, a side… Read More »

Prostate cancer symptoms: This unpleasant sensation may signify the disease has spread

Prostate cancer is cancer that occurs in the prostate — a small walnut-shaped gland in men that produces the seminal fluid that nourishes and transports sperm. Symptoms of prostate cancer do not usually appear until the prostate is large enough to affect the tube that carries urine from the bladder out of the penis (urethra).… Read More »

‘Search and destroy’ radiotherapy for prostate cancer being hailed as a game changer

CHICAGO — A game-changing “search and destroy” treatment could offer hope of a longer life to thousands of men with incurable prostate cancer. The first two British patients were treated last weekend, after research found that it could significantly extend survival for men with no other options. Charities said they were “thrilled” by the promise… Read More »

Avenda Health Uses Artificial Intelligence to Improve Prostate Cancer Treatment

Prostate cancer affects 1 in 9 men and is one of the most common cancers in the United States. Due to the close anatomical association between the prostate and nearby organs, well-known complications of prostate cancer treatment are urinary incontinence and erectile dysfunction. Santa Monica-based Avenda Health hopes to use artificial intelligence to decrease rates… Read More »

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »